home / United States / Geron

Geron Market Cap

$1.78 B

-5.98 M

NASDAQ:GERN · January 22, 2025

Share price

$2.95

Enterprise Value

$1.54 B

Change (1-Year)

35.7%

Global Rank

#4322

Country Rank

#1606

Regions

USA

Market cap

As of January 22, 2025, Geron (GERN) has a market cap of $1.78 billion USD. According to our data, Geron is ranked No.4322 in global market value.

Sector Rank:

Biotech #214 Pharmaceuticals #195

GERN Market Capitalization Growth

30D Growth:

-13.5%

1 Years Growth:

35.7%

3 Years Growth:

160.4%

5 Years Growth:

106.4%

10 Years Growth:

-10.5%

15 Years Growth:

-46.5%

20 Years Growth:

-62.0%

Total Growth:

-60%

Geron Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Geron Market Cap CAGR Chart

Geron Market Cap History 1996 - 2025

Year	Market Cap	%Change
Jan 22, 2025	$1.78 B	-16.66%
Dec 31, 2024	$2.14 B	67.77%
Dec 29, 2023	$1.28 B	-12.81%
Dec 30, 2022	$1.46 B	98.36%
Dec 31, 2021	$0.74 B	-23.27%
Dec 31, 2020	$0.96 B	16.91%
Dec 31, 2019	$0.82 B	36.00%
Dec 31, 2018	$0.60 B	-44.44%
Dec 29, 2017	$1.09 B	-13.04%
Dec 30, 2016	$1.25 B	-57.23%
Dec 31, 2015	$2.93 B	48.92%
Dec 31, 2014	$1.96 B	-27.46%
Dec 31, 2013	$2.71 B	236.17%
Dec 31, 2012	$0.81 B	-4.73%
Dec 30, 2011	$0.85 B	-71.48%
Dec 31, 2010	$2.97 B	-6.49%
Dec 31, 2009	$3.17 B	18.84%
Dec 31, 2008	$2.67 B	-17.78%
Dec 31, 2007	$3.25 B	-35.31%
Dec 29, 2006	$5.02 B	1.97%
Dec 30, 2005	$4.92 B	8.03%
Dec 31, 2004	$4.55 B	-20.06%
Dec 31, 2003	$5.70 B	176.94%
Dec 31, 2002	$2.06 B	-58.62%
Dec 31, 2001	$4.97 B	-43.64%
Dec 29, 2000	$8.82 B	22.28%
Dec 31, 1999	$7.21 B	16.09%
Dec 31, 1998	$6.21 B	31.82%
Dec 31, 1997	$4.71 B	-37.74%
Dec 31, 1996	$7.57 B	100%

Similar Companies to Geron

Name	Market Cap	Market cap difference	Regions
Sangamo Therapeutics SGMO	$0.23 B	-0.000 M	USA
CRISPR Therapeutics CRSP	$3.82 B	6.828 M	Switzerland
Editas Medicine EDIT	$0.10 B	-0.000 M	USA
Intellia Therapeutics NTLA	$1.03 B	0.000 M	USA
bluebird bio BLUE	$77.02 M	0.000 M	USA
Fate Therapeutics FATE	$0.15 B	-0.000 M	USA
Mesoblast MESO	$2.03 B	-0.052 B	Australia
Vericel VCEL	$2.96 B	24.432 M	USA
BrainStorm Cell Therapeutics BCLI	$12.66 M	0.000 M	USA
Lineage Cell Therapeutics LCTX	$0.15 B	-0.000 M	USA

About Geron Inc.

Name

Geron Corporation

Website

https://www.geron.com

Headquarters

Foster City,CA

symbol

GERN

CURRENCY

USD

country

United States

fullTimeEmployees

141

exchange

NMS

firstTradeDateEpochUtc

1996/07/31

GERN Market Cap Formula

Market Cap	=	GERN Stock Price	*	GERN Shares Outstanding
	=	$2.95	*	0.60 B
	=	$1.78 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe